These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31921204)

  • 1. Exome Sequencing Identifies Susceptibility Loci for Sarcoidosis Prognosis.
    Lahtela E; Kankainen M; Sinisalo J; Selroos O; Lokki ML
    Front Immunol; 2019; 10():2964. PubMed ID: 31921204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole Exome Sequencing Identified Two Single Nucleotide Polymorphisms of Human Leukocyte Antigen-DRB5 in Familial Sarcoidosis in China.
    Zhang Q; Xu Z; Huang H; Zhang M
    Curr Gene Ther; 2023; 23(3):215-227. PubMed ID: 36658707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease marker combination enhances patient characterization in the Finnish sarcoidosis patients.
    Lahtela E; Wolin A; Pietinalho A; Lokki ML; Selroos O
    Respir Med; 2017 Nov; 132():92-94. PubMed ID: 29229112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNP Variants in Major Histocompatibility Complex Are Associated with Sarcoidosis Susceptibility-A Joint Analysis in Four European Populations.
    Wolin A; Lahtela EL; Anttila V; Petrek M; Grunewald J; van Moorsel CHM; Eklund A; Grutters JC; Kolek V; Mrazek F; Kishore A; Padyukov L; Pietinalho A; Ronninger M; Seppänen M; Selroos O; Lokki ML
    Front Immunol; 2017; 8():422. PubMed ID: 28469621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DRB1 allele frequencies and C4 copy number variation in Finnish sarcoidosis patients and associations with disease prognosis.
    Wennerström A; Pietinalho A; Vauhkonen H; Lahtela L; Palikhe A; Hedman J; Purokivi M; Varkki E; Seppänen M; Lokki ML; Selroos O;
    Hum Immunol; 2012 Jan; 73(1):93-100. PubMed ID: 22074998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis.
    Spagnolo P; Sato H; Grutters JC; Renzoni EA; Marshall SE; Ruven HJ; Wells AU; Tzouvelekis A; van Moorsel CH; van den Bosch JM; du Bois RM; Welsh KI
    Tissue Antigens; 2007 Sep; 70(3):219-27. PubMed ID: 17661910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole exome sequencing in three families segregating a pediatric case of sarcoidosis.
    Calender A; Rollat Farnier PA; Buisson A; Pinson S; Bentaher A; Lebecque S; Corvol H; Abou Taam R; Houdouin V; Bardel C; Roy P; Devouassoux G; Cottin V; Seve P; Bernaudin JF; Lim CX; Weichhart T; Valeyre D; Pacheco Y; Clement A; Nathan N;
    BMC Med Genomics; 2018 Mar; 11(1):23. PubMed ID: 29510755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of genetic risk, its clinical manifestation and disease management based on 18 susceptibility gene markers among West-Slavonic patients with sarcoidosis.
    Kishore A; Sikorova K; Kocourkova L; Petrkova J; Doubkova M; Jakubec P; Rębała K; Dubaniewicz A; Petrek M
    Gene; 2023 Aug; 878():147577. PubMed ID: 37336276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk.
    Fischer A; Ellinghaus D; Nutsua M; Hofmann S; Montgomery CG; Iannuzzi MC; Rybicki BA; Petrek M; Mrazek F; Pabst S; Grohé C; Grunewald J; Ronninger M; Eklund A; Padyukov L; Mihailovic-Vucinic V; Jovanovic D; Sterclova M; Homolka J; Nöthen MM; Herms S; Gieger C; Strauch K; Winkelmann J; Boehm BO; Brand S; Büning C; Schürmann M; Ellinghaus E; Baurecht H; Lieb W; Nebel A; Müller-Quernheim J; Franke A; Schreiber S;
    Am J Respir Crit Care Med; 2015 Sep; 192(6):727-36. PubMed ID: 26051272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Löfgren's syndrome.
    Spagnolo P; Sato H; Grunewald J; Brynedal B; Hillert J; Mañá J; Wells AU; Eklund A; Welsh KI; du Bois RM
    J Intern Med; 2008 Nov; 264(5):433-41. PubMed ID: 18513341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome Sequencing Reveals Genetic Variability and Identifies Chronic Prognostic Loci in Chinese Sarcoidosis Patients.
    Zhang Q; Huang H; Zhang M; Fang C; Wang N; Jing X; Guo J; Sun W; Yang X; Xu Z
    Front Oncol; 2022; 12():910227. PubMed ID: 35860586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The investigation of HLA microsatellites influence in predisposition to sarcoidosis among Croatians.
    Grubić Z; Peros-Golubicić T; Stingl K; Zunec R
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Jul; 28(1):18-26. PubMed ID: 21796887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Whole exome sequencing and analysis of a Chinese family with familial pulmonary sarcoidosis].
    Zhang Q; Huang H; Wang N; Fang CL; Jing XY; Guo J; Sun W; Yu C; Yang XY; Xu ZJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jun; 43(6):525-531. PubMed ID: 32486560
    [No Abstract]   [Full Text] [Related]  

  • 14. Familial sarcoidosis is linked to the major histocompatibility complex region.
    Schürmann M; Lympany PA; Reichel P; Müller-Myhsok B; Wurm K; Schlaak M; Müller-Quernheim J; du Bois RM; Schwinger E
    Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):861-4. PubMed ID: 10988096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of genetic variants in
    Davoudi S; Chang VS; Navarro-Gomez D; Stanwyck LK; Sevgi DD; Papavasileiou E; Ren A; Uchiyama E; Sullivan L; Lobo AM; Papaliodis GN; Sobrin L
    Mol Vis; 2018; 24():59-74. PubMed ID: 29416296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-Küster-Hauser syndrome.
    Chen MJ; Wei SY; Yang WS; Wu TT; Li HY; Ho HN; Yang YS; Chen PL
    Hum Reprod; 2015 Jul; 30(7):1732-42. PubMed ID: 25924657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole exome sequencing of a German sarcoidosis family with four affected and one spontaneous remission case.
    Kvacskay P; El Jammal T; Lorenz HM; Pacheco Y; Calender A
    Rheumatology (Oxford); 2024 May; 63(6):1512-1517. PubMed ID: 37478346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic characterization and susceptibility for sarcoidosis in Japanese patients: risk factors of BTNL2 gene polymorphisms and HLA class II alleles.
    Suzuki H; Ota M; Meguro A; Katsuyama Y; Kawagoe T; Ishihara M; Asukata Y; Takeuchi M; Ito N; Shibuya E; Nomura E; Uemoto R; Nishide T; Namba K; Kitaichi N; Morimoto S; Kaburaki T; Ando Y; Takenaka S; Nakamura J; Saeki K; Ohno S; Inoko H; Mizuki N
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7109-15. PubMed ID: 22991420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups.
    Sato H; Woodhead FA; Ahmad T; Grutters JC; Spagnolo P; van den Bosch JM; Maier LA; Newman LS; Nagai S; Izumi T; Wells AU; du Bois RM; Welsh KI
    Hum Mol Genet; 2010 Oct; 19(20):4100-11. PubMed ID: 20685690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigen-A, -B, and -DRB1 alleles and sarcoidosis in Chinese Han subjects.
    Zhou Y; Shen L; Zhang Y; Jiang D; Li H
    Hum Immunol; 2011 Jul; 72(7):571-5. PubMed ID: 21513758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.